<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Durogesic DTrans; Fentanyl: analgesia" /><meta name="IX" content="Durogesic DTrans; Fentanyl: analgesia" /><title>Durogesic DTrans®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="27054.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="27054.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=27054.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2055.htm">4 Central nervous system</a> &gt; <a href="3456.htm">4.7 Analgesics</a> &gt; <a href="3491.htm">4.7.2 Opioid analgesics</a> &gt; <a href="3530.htm">FENTANYL</a> &gt; <a href="129814.htm">Patches</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="3528.htm" title="Previous: DIPIPANONE HYDROCHLORIDE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="65271.htm" title="Next: HYDROMORPHONE HYDROCHLORIDE">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a382519.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fentanyl Citrate</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Central Nervous System Agents 28:00 &gt; Analgesics and Antipyretics 28:08 &gt; Opiate Agonists 28:08.08</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/12127-z.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Fentanyl</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: F &gt; Interactions of Fentanyl</p></div></li></ul><ul><li><h3>British National Formulary (14)</h3></li><li><a href="29450.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pain</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Guidance on prescribing &gt; Prescribing in palliative care</p></div></li><li><a href="3491.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">4.7.2 Opioid analgesics</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.7 Analgesics</p></div></li><li><a href="3530.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">FENTANYL</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.7 Analgesics &gt; 4.7.2 Opioid analgesics</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22fentanyl%22%22fentanyl%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (14)</a></li></ul><ul><li><h3>BNF for Children (9)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/29450.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pain</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; General guidance &gt; Prescribing in palliative care</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/3530.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">FENTANYL</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.7 Analgesics &gt; 4.7.2 Opioid analgesics</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/106077.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Actiq®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.7 Analgesics &gt; 4.7.2 Opioid analgesics &gt; FENTANYL &gt; Lozenges</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22fentanyl%22%22fentanyl%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (9)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/c-d1e495336.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fentanyl</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; F</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a582083.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fentanyl Citrate</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; F</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0006s0056.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fentanyl</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; F</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/f01-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fentanyl</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; F</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/ms-12127-z.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fentanyl</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Analgesics Anti-inflammatory Drugs and Antipyretics &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/8817-b.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">β-Hydroxy-3-methylfentanyl</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Additional Substances of Medical Interest &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/04001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fentanyl</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; F &gt; FE</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E26E3E0R0D135.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Fentanyl</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; F</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c150.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fentanyl</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; F</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_3530">FENTANYL</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i95.htm" title="Go to appendix 1">Fentanyl</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">severe chronic pain, breakthrough pain; parenteral indications (<a title=" Opioid analgesics" href="6621.htm#_6621">section 15.1.4.3</a>)</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">see <a title="target-block: OPIOID ANALGESIC CAUTIONS" href="3491.htm#_200091">notes above</a>; also <span id="_200543">diabetes
mellitus, impaired consciousness, cerebral tumour</span>; see also <a title="BNF:preparation-group: Patches" href="129814.htm#_129814">Transdermal Fentanyl</a></p></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">see <a title="target-block: OPIOID ANALGESIC CONTRA-INDICATIONS" href="3491.htm#_200093">notes above</a></p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">see <a title="BNF:target-block: hepatic, renal and pregnancy opioids " href="3491.htm#_204134">notes above</a></p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">see <a title="BNF:target-block: hepatic, renal and pregnancy opioids " href="3491.htm#_204134">notes above</a></p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">see <a title="BNF:target-block: hepatic, renal and pregnancy opioids " href="3491.htm#_204134">notes above</a></p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">monitor infant for opioid-induced side-effects</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">see <a title="BNF:target-block: OPIOID ANALGESIC SIDE-EFFECTS" href="3491.htm#_200095">notes above</a>; also
abdominal pain, dyspepsia, diarrhoea, gastro-oesophageal reflux disease,
stomatitis, anorexia, hypertension, vasodilation, dyspnoea, aesthenia,
myoclonus, anxiety, tremor, appetite changes, rhinitis, pharyngitis,
paraesthesia, application-site reactions; <i>less commonly</i> ileus, flatulence, hypoventilation, impaired concentration, impaired
coordination, amnesia, speech disorder, malaise, seizures, pyrexia,
thirst, blood disorders (including thrombocytopenia), chills; <i>rarely</i> hiccups; <i>very rarely</i> arrhythmia,
apnoea, haemoptysis, ataxia, delusions, bladder pain</p></div><div class="cAF"><h2>Dose</h2> <p class="cR">Chronic intractable pain, <span class="cU">by transdermal route</span>, apply to dry, non-irritated, non-irradiated, non-hairy skin on
torso or upper arm, removing after 72 hours and siting replacement
patch on a different area (avoid using the same area for several days). <span class="cAK">adult</span> over 16 years <b>not currently treated</b> with a strong opioid analgesic (but see <a title="BNF:preparation-group: Patches" href="129814.htm#_129814">Transdermal Fentanyl</a>), initial dose, one ‘12’ or ‘25 micrograms/hour’
patch replaced after 72 hours; <span class="cAK">adult</span> and <span class="cAK">child</span> over 2 years <b>currently
treated</b> with a strong opioid analgesic, initial dose based
on previous 24-hour opioid requirement (consult product literature)</p><div class="cAT"><h3>Dose adjustment</h3> <p class="cAX">When starting, evaluation of the
analgesic effect should <b>not</b> be made before the system
has been worn for <b>24 hours</b> (to allow for the gradual
increase in plasma-<span>fentanyl</span> concentration)—previous
analgesic therapy should be phased out gradually from time of first
patch application; if necessary dose should be adjusted at 48–72-hour
intervals in steps of 12–25 micrograms/hour. More than one patch may
be used at a time (but applied at the <i>same time</i> to
avoid confusion)—consider additional or alternative analgesic therapy
if dose required exceeds 300 micrograms/hour (<b>important:</b> it may take up to 25 hours for the plasma-<span>fentanyl</span> concentration to decrease by 50%—replacement opioid therapy should
be initiated at a low dose and increased gradually).</p></div><div class="cAT"><h3>Long duration of action</h3> <p class="cAX">In view of the long duration
of action, patients who have had severe side-effects should be monitored
for up to 24 hours after patch removal</p></div><p class="cR">Breakthrough pain, see under oral preparations</p><div class="cAR"><h3>Conversion</h3> <p class="cAX">(from oral morphine to transdermal
fentanyl) see <a title="target-block: fentanyl transdermal route palliative care" href="29450.htm#_120544">Prescribing in Palliative
Care</a></p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_201310__201310"><a href="201310.htm#_201310" title="Tablets">Tablets</a><ul style="display: none"><li><a href="201311.htm#_201311" title="Abstral®">Abstral®</a></li><li><a href="202699.htm#_202699" title="Effentora®">Effentora®</a></li></ul></li><li id="_129813__129813"><a href="129813.htm#_129813" title="Lozenges">Lozenges</a><ul style="display: none"><li><a href="106077.htm#_106077" title="Actiq®">Actiq®</a></li></ul></li><li id="_204139__204139"><a href="204139.htm#_204139" title="Nasal spray">Nasal spray</a><ul style="display: none"><li><a href="204140.htm#_204140" title="Instanyl®">Instanyl®</a></li><li><a href="213664.htm#_213664" title="PecFent®">PecFent®</a></li></ul></li><li><h1 class="title">Patches</h1><div class="cN"><h3 class="cBP">Transdermal fentanyl</h3><div class="cAV"><h3>Fever or external heat</h3> <p class="cAX">Monitor patients using
patches for increased side-effects if fever present (increased absorption
possible); avoid exposing application site to external heat, for example
a hot bath or sauna (may also increase absorption)<span id="_214121"></span></p></div><div class="cAV"><h3>Respiratory depression</h3> <p class="cAX">Risk of fatal respiratory
depression, particularly in patients not previously treated with a
strong opioid analgesic; manufacturer recommends use only in opioid
tolerant patients</p></div><div class="cAV"><h3>Counselling</h3> <p class="cAX">Patients and carers should be informed
about safe use, including correct administration and disposal, strict
adherence to dosage instructions, and the symptoms and signs of opioid
overdosage. Patches should be removed immediately in case of breathing
difficulties, marked drowsiness, confusion, dizziness, or impaired
speech, and patients and carers should seek prompt medical attention.</p></div></div><div class="cAV"><h3>Prescriptions</h3> <p class="cAX">Prescriptions for <span>fentanyl</span> patches can be written to show the strength in terms of the release
rate and it is acceptable to write ‘<i>Fentanyl 25 patches</i>’ to prescribe patches that release <span>fentanyl</span> 25 micrograms
per hour. The dosage should be expressed in terms of the interval
between applying a patch and replacing it with a new one, e.g. ‘<i>one patch to be applied every 72 hours</i>’. The total quantity
of patches to be supplied should be written in words and figures.</p></div><ul><li><a href="129815.htm#_129815" title="Fentanyl">Fentanyl</a></li><li class="jN" id="_27054" style="margin: 0 0 0 20px;"><h1 class="title">Durogesic DTrans®<span> (<a href="appendix-112803-J.htm#m401">Janssen</a>)</span> <a href="29424.htm#_120032" title="Schedule 2 Controlled Drug"><img class="cJ" src="images/cd2_l.png" alt="Schedule 2 Controlled Drug" /></a></h1><div class="cAY"><span class="cAB">Patches</span>, self-adhesive, transparent, <span>fentanyl</span>, ‘12’ patch (releasing approx. 12 micrograms/hour
for 72 hours), net price 5 = £13.69; ‘25’ patch (releasing approx.
25 micrograms/hour for 72 hours), 5 = £19.59; ‘50’ patch (releasing
approx. 50 micrograms/hour for 72 hours), 5 = £36.59; ‘75’ patch (releasing
approx. 75 micrograms/hour for 72 hours), 5 = £50.99; ‘100’ patch
(releasing approx. 100 micrograms/hour for 72 hours), 5 = £62.89. 
    Label:
    2, counselling, <a title="BNF:preparation-group: Patches" href="129814.htm#_129814">administration</a></div></li></ul></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="3528.htm">Previous: DIPIPANONE HYDROCHLORIDE</a> | <a class="top" href="27054.htm#">Top</a> | <a accesskey="]" href="65271.htm">Next: HYDROMORPHONE HYDROCHLORIDE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>